Evidence map›Paper›PMID 29487802›Full record

ArticleToxicology reports2018

Protective role of

Rupal Purena, Rohit Seth, Renu Bhatt

Open access · goldAbstract read
In one paragraph

Article in Toxicology reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. TheCurrent topics in medicinal chemistry · 2024
    Review
  6. Attenuation of Hyperlipidemia by Medicinal Formulations ofBioengineering (Basel, Switzerland) · 2023
    Review
  7. Functional and Nutraceutical Significance of Amla (Antioxidants (Basel, Switzerland) · 2022
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Renoprotective effects of stevia (Toxicology reports · 2019
    Article
  16. Article
  17. Dose-response : a publication of International Hormesis Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Rupal PurenaDepartment of Biotechnology, Guru Ghasidas Vishwavidyalaya, Bilaspur, 495009, Chhattisgarh, India.
Rohit SethDepartment of Zoology, Guru Ghasidas Vishwavidyalaya, Bilaspur, 495009, Chhattisgarh, India.
Renu BhattDepartment of Biotechnology, Guru Ghasidas Vishwavidyalaya, Bilaspur, 495009, Chhattisgarh, India.
Guru Ghasidas Vishwavidyalaya · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nephrotoxicity is a major limiting factor in cisplatin treatment. In the present study hydro-ethanolic leaf extract of

Indexed as

BSA, bovine serum albuminBUN, blood urea nitrogenBW, body weightCAT, catalaseCisplatinDMSO, dimethyl sulfoxideDNA, deoxy-ribonucleic acidDTNB, 5,5-dithio-bis(2-nitrobenzoic acid)Emblica officinalisFDA, food and drug administrationGAMT, guanidinoacetate methyltransferaseGPx, glutathione peroxidaseGR, glutathione reductaseH&E, hematoxylene and eosinMDA, malondialdehydeNaCl, sodium chlorideNADPH, nicotinamide adenine dinucleotide phosphateNephrotoxicityOxidative stressRatsRBCs, red blood cellsRNS, reactive nitrogen speciesROS, reactive oxygen speciesSEM, standard error meanSOD, superoxide dismutaseTBA, 2-thiobarbituric acidTCA, trichloroacetic acid

Identifiers

PMID29487802
PMCPMC5814364
OpenAlexW2791600655

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.